Drug Shortage Report for ERWINASE

Last updated on 2021-03-16 History
Report ID 62731
Drug Identification Number 02237815
Brand name ERWINASE
Common or Proper name L-asparaginase
Company Name JAZZ PHARMACEUTICALS FRANCE SAS
Market Status CANCELLED POST MARKET
Active Ingredient(s) ASPARAGINASE
Strength(s) 10000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 5 vials per box
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-10-01
Estimated end date Unknown
Actual end date 2021-03-10
Shortage status Resolved
Updated date 2021-03-16
Company comments Delays in the manufacture of the drug.
Health Canada comments
Contact Address 84 QUAI CHARLES DE GAULLE CITY ONE
LYON, AUVERGNE-RHONE-ALPES
FRANCE 69006
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-03-16 French Compare
v6 2021-03-16 English Compare
v5 2018-11-19 French Compare
v4 2018-11-19 English Compare
v3 2018-10-02 English Compare
v2 2018-10-01 French Compare
v1 2018-10-01 English Compare